• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The pattern and clinicopathological correlates of programmed death-ligand 1 expression in cutaneous squamous cell carcinoma.

作者信息

Schaper K, Köther B, Hesse K, Satzger I, Gutzmer R

机构信息

Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.

出版信息

Br J Dermatol. 2017 May;176(5):1354-1356. doi: 10.1111/bjd.14955. Epub 2017 Mar 8.

DOI:10.1111/bjd.14955
PMID:27516151
Abstract
摘要

相似文献

1
The pattern and clinicopathological correlates of programmed death-ligand 1 expression in cutaneous squamous cell carcinoma.皮肤鳞状细胞癌中程序性死亡配体1表达的模式及临床病理相关性
Br J Dermatol. 2017 May;176(5):1354-1356. doi: 10.1111/bjd.14955. Epub 2017 Mar 8.
2
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients.肿瘤细胞 PD-L1 表达阴性而免疫细胞 PD-L1 表达阳性是头颈部肿瘤患者的预后良好因素。
Sci Rep. 2016 Nov 14;6:36956. doi: 10.1038/srep36956.
3
Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.程序性死亡-1配体1和2在皮肤鳞状细胞癌中的表达及其与肿瘤浸润树突状细胞的关系。
Clin Exp Immunol. 2017 Jun;188(3):420-429. doi: 10.1111/cei.12921. Epub 2017 Mar 12.
4
Prognostic value of tumor PD-L1 expression combined with CD8 tumor infiltrating lymphocytes in high grade serous ovarian cancer.肿瘤 PD-L1 表达联合 CD8 肿瘤浸润淋巴细胞对高级别浆液性卵巢癌的预后价值。
Int Immunopharmacol. 2017 Nov;52:7-14. doi: 10.1016/j.intimp.2017.08.017. Epub 2017 Aug 31.
5
PD/L1 in oral squamous cell carcinoma.口腔鳞状细胞癌中的程序性死亡受体 1/程序性死亡配体 1
J BUON. 2018 May-Jun;23(3):835-836.
6
The mechanism of de novo expression of programmed cell death-ligand 1 in squamous cell carcinoma of the lung.新表达的程序性细胞死亡配体 1 在肺鳞状细胞癌中的作用机制。
Oncol Rep. 2017 Oct;38(4):2189-2196. doi: 10.3892/or.2017.5876. Epub 2017 Aug 3.
7
Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.II期和III期胃癌患者中基于PD-L1表达和CD8阳性肿瘤浸润淋巴细胞的免疫分类的临床病理意义
Oncotarget. 2017 Apr 18;8(16):26356-26367. doi: 10.18632/oncotarget.15465.
8
Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma.口腔鳞状细胞癌中 PD-L1 表达与肿瘤浸润淋巴细胞的关系。
Oral Oncol. 2011 Dec;47(12):1148-53. doi: 10.1016/j.oraloncology.2011.08.007. Epub 2011 Sep 10.
9
Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8 Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis.化疗放疗诱导的程序性死亡配体1和CD8肿瘤浸润淋巴细胞改变可识别直肠癌预后不良患者：一项配对比较分析
Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1216-1224. doi: 10.1016/j.ijrobp.2017.07.004.
10
Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.评估非小细胞肺癌中的PDL-1和PD-1：一种新型免疫评分方法。
Clin Lung Cancer. 2017 Mar;18(2):220-233.e8. doi: 10.1016/j.cllc.2016.09.009. Epub 2016 Oct 5.

引用本文的文献

1
Can the co-localization of CD8+, PD-1, PD-L1 AND PD-L2 patterns provide guidance in clinical outcomes of patients with head and neck cutaneous squamous cell carcinoma?CD8+、PD-1、PD-L1和PD-L2模式的共定位能否为头颈部皮肤鳞状细胞癌患者的临床预后提供指导？
Braz J Otorhinolaryngol. 2025 May 24;91(5):101632. doi: 10.1016/j.bjorl.2025.101632.
2
Immune Checkpoints and Cellular Landscape of the Tumor Microenvironment in Non-Melanoma Skin Cancer (NMSC).非黑色素瘤皮肤癌（NMSC）中的肿瘤微环境免疫检查点和细胞景观。
Cells. 2024 Sep 26;13(19):1615. doi: 10.3390/cells13191615.
3
Relationship Between PD-L1, PD-1, CD8 and Clinicopathological Factors in Primary SCCs.
原发性鳞状细胞癌中PD-L1、PD-1、CD8与临床病理因素之间的关系
Dermatol Pract Concept. 2024 Jul 1;14(3):e2024176. doi: 10.5826/dpc.1403a176.
4
Exploring the Functions of Mutant p53 through Knockout in HaCaT Keratinocytes.通过敲除HaCaT角质形成细胞探索突变型p53的功能。
Curr Issues Mol Biol. 2024 Feb 8;46(2):1451-1466. doi: 10.3390/cimb46020094.
5
Inhibition of UV-Induced Stress Signaling and Inflammatory Responses in SKH-1 Mouse Skin by Topical Small-Molecule PD-L1 Blockade.局部小分子程序性死亡配体1（PD-L1）阻断对SKH-1小鼠皮肤紫外线诱导的应激信号和炎症反应的抑制作用
JID Innov. 2024 Jan 5;4(2):100255. doi: 10.1016/j.xjidi.2023.100255. eCollection 2024 Mar.
6
Monoclonal antibodies for the treatment of squamous cell carcinoma: A literature review.用于治疗鳞状细胞癌的单克隆抗体：文献综述。
Cancer Rep (Hoboken). 2023 May;6(5):e1802. doi: 10.1002/cnr2.1802. Epub 2023 Apr 12.
7
Review: PD-L1 as an emerging target in the treatment and prevention of keratinocytic skin cancer.综述：PD-L1 作为治疗和预防角化细胞皮肤癌的新兴靶点。
Mol Carcinog. 2023 Jan;62(1):52-61. doi: 10.1002/mc.23464. Epub 2022 Sep 19.
8
Relationship between PD-L1 expression and prognostic factors in high-risk cutaneous squamous and basal cell carcinoma.PD-L1 表达与高危皮肤鳞状细胞癌和基底细胞癌预后因素的关系。
Bosn J Basic Med Sci. 2022 Oct 23;22(6):894-900. doi: 10.17305/bjbms.2022.7574.
9
Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response.非黑色素瘤皮肤癌患者中免疫治疗候选者的识别：反应潜在预测因素综述
J Clin Med. 2022 Jun 11;11(12):3364. doi: 10.3390/jcm11123364.
10
Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma.晚期皮肤鳞状细胞癌中新兴的精准诊断方法
NPJ Precis Oncol. 2022 Mar 23;6(1):17. doi: 10.1038/s41698-022-00261-z.